Clinical Trial Update: Understanding the Pathogenesis and Treatment of Childhood Onset Dermatomyositis [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial investigating the pathogenesis and treatment of childhood-onset dermatomyositis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dermatomyositis

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Dermatomyositis | Phase 2, Phase 3 | Status: TERMINATED